Lucid Diagnostics Inc.
$1.3
▼
-0.87%
2026-04-21 07:59:01
www.luciddx.com
NCM: LUCD
Explore Lucid Diagnostics Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$221.18 M
Current Price
$1.3
52W High / Low
$1.7 / $0.95
Stock P/E
—
Book Value
$-0.33
Dividend Yield
—
ROCE
-418.44%
ROE
-7.11%
Face Value
—
EPS
$-0.69
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
82
Beta
1.25
Debt / Equity
236.1
Current Ratio
1.31
Quick Ratio
1.3
Forward P/E
-6.22
Price / Sales
41.63
Enterprise Value
$240.32 M
EV / EBITDA
-4.93
EV / Revenue
51.07
Rating
Strong Buy
Target Price
$4.1
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Leverage is relatively high.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Modular Medical, Inc. | $5.41 | — | $27.31 M | — | -109.03% | -3.32% | $34.5 / $3.55 | $2.27 |
| 2. | Integer Holdings Corporation | $89.32 | 29.89 | $3.07 B | — | 7.52% | 6.11% | $127.56 / $62 | $50.85 |
| 3. | SI-BONE, Inc. | $14.32 | — | $632.45 M | — | -10.47% | -10.97% | $21.89 / $12.15 | $4.07 |
| 4. | Nuwellis, Inc. | $1.16 | — | $2.85 M | — | -359.88% | -3.83% | $45.42 / $0.96 | $1.56 |
| 5. | Pulsenmore Ltd. | $3.33 | — | $72.38 M | — | -33.09% | -17.62% | $1,468 / $1,000 | — |
| 6. | Adagio Medical Holdings, Inc. | $1.53 | — | $34.43 M | — | -62.51% | -1.55% | $2.87 / $0.74 | $0.56 |
| 7. | Autonomix Medical, Inc. | $0.4 | — | $4.63 M | — | -143.08% | -1.89% | $2.82 / $0.34 | $0.75 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 1.5 M | 1.21 M | 1.16 M | 0.83 M | 1.2 M | — |
| Operating Profit | -14.01 M | -11.76 M | -11.38 M | -12.49 M | -12.38 M | — |
| Net Profit | -16.27 M | -10.4 M | -4.44 M | -26.91 M | -11.54 M | — |
| EPS in Rs | -0.1 | -0.06 | -0.03 | -0.16 | -0.07 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 4.71 M | 4.35 M | 2.43 M | 0.38 M |
| Operating Profit | -49.64 M | -46.05 M | -48.48 M | -56.25 M |
| Net Profit | -58.01 M | -45.53 M | -52.67 M | -56.17 M |
| EPS in Rs | -0.34 | -0.27 | -0.31 | -0.33 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 40.45 M | 30.71 M | 27.27 M | 32.51 M |
| Total Liabilities | 29.51 M | 25.32 M | 29.58 M | 9.46 M |
| Equity | 10.94 M | 5.39 M | -2.31 M | 23.05 M |
| Current Assets | 37.47 M | 25.15 M | 22.07 M | 24.36 M |
| Current Liabilities | 28.58 M | 23.52 M | 29.38 M | 8.43 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -46.48 M | -44.14 M | -32.82 M | -29.68 M |
| Investing CF | -0.2 M | -0.65 M | -0.22 M | -4.11 M |
| Financing CF | 59.03 M | 48.25 M | 29.46 M | 2.61 M |
| Free CF | -46.68 M | -44.79 M | -33.04 M | -30.59 M |
| Capex | -0.2 M | -0.65 M | -0.22 M | -0.91 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue Growth % | 8.28% | 79% | 544.03% | — |
| Earnings Growth % | -27.41% | 13.55% | 6.24% | — |
| Profit Margin % | -1232.68% | -1047.61% | -2169.11% | -14899.47% |
| Operating Margin % | -1054.82% | -1059.64% | -1996.79% | -14920.69% |
| Gross Margin % | -41.73% | -63.35% | -146.25% | -858.62% |
| EBITDA Margin % | -1213.68% | -1020.16% | -2049.05% | -14383.82% |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.